Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Juan Uriz"'
Autor:
Leire Leache, Marta Gutiérrez‐Valencia, Luis Carlos Saiz, Juan Uriz, Federico Bolado, José Antonio García‐Erce, Lorenzo Cantarelli, Juan Erviti
Publikováno v:
Alimentary Pharmacology & Therapeutics. 57:620-634
Albumin is used in multiple situations in patients with cirrhosis, but the evidence of its benefit is not always clear. The aim was to synthesise the evidence on the efficacy and safety of albumin compared to other treatments or no active interventio
Autor:
Leire Leache, Marta Gutiérrez‐Valencia, Luis Carlos Saiz, Juan Uriz, Federico Bolado, José Antonio García‐Erce, Lorenzo Cantarelli, Juan Erviti
Publikováno v:
Alimentary Pharmacology & Therapeutics. 57:1484-1485
Publikováno v:
Revista Española de Enfermedades Digestivas. 115
Ascites is the most frequent complication of cirrhosis and carries with it a high morbidity and mortality. The results of the ANSWER study and others like it open the possibility of considering the prolonged administration of albumin, as an effective
Autor:
Ramon Planas, Pere Ginès, Vicente Arroyo, Luis Ruiz del Arbol, Juan Uriz, Mónica Guevara, Marta Martín-Llahí, Carlos Guarner, Javier Crespo, José Ríos, María E. Baccaro, Rafael Bañares, Alberto Monescillo
Publikováno v:
Liver International. 30:1137-1142
Hyponatraemia is common in patients with advanced cirrhosis and is associated with remarkable changes in brain cells, particularly a reduction in myoinositol and other intracellular organic osmolytes related to the hypo-osmolality of the extracellula
Autor:
Pere Ginès, Guadalupe Garcia–Tsao, Juan Uriz, Patrick S. Kamath, Jaime Bosch, B. Calahorra, Vicente Arroyo, Ramon Planas, Juan Rodés, Luis Ruiz del Arbol
Publikováno v:
Gastroenterology. 123:1839-1847
Background & Aims: The transjugular intrahepatic portosystemic shunt (TIPS) has been shown to be more effective than repeated paracentesis plus albumin in the control of refractory ascites. However, its effect on survival and healthcare costs is stil
Autor:
Mónica Guevara, Juan Uriz, Pere Ginès, Dara De Las Heras, B. Calahorra, Rolando Ortega, Juan Rodés, Andrés Cárdenas, Ramon Bataller, Wladimiro Jiménez, Vicente Arroyo
Publikováno v:
Hepatology. 36:941-948
Vasopressin analogues associated with albumin improve renal function in hepatorenal syndrome (HRS). The current study was aimed at assessing the efficacy of the treatment, predictive factors of response, recurrence of HRS, and survival after therapy.
Autor:
Juan Rodés, Wladimiro Jiménez, Vicente Arroyo, Pau Sort, Rolando Ortega, B. Calahorra, Ramon Bataller, Pere Ginès, Juan Uriz, Andrés Cárdenas, Francisca Rivera, Javier Fernández
Publikováno v:
Journal of Hepatology. 36:349-355
To investigate the relationship between neuropeptide Y (NPY), a potent renal vasoconstrictor peptide released upon marked stimulations of sympathetic nervous system (SNS), and renal and circulatory function in cirrhosis.Plasma levels of NPY (radioimm
Autor:
Miquel Bruguera, Antoni Rimola, Carolina Soguero, Roberto Segovia, Josep Costa, Juan Uriz, Alberto Sanchez-Fueyo, Luis Grande
Publikováno v:
Liver Transplantation. 7:106-112
De novo hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT) is commonly believed to be a relatively benign condition, in contrast to post-OLT infection recurrence, considered a very aggressive complication. We reviewed the
Autor:
Llorenç Quintó, Wladimiro Jiménez, Pau Sort, Juan Uriz, Pere Ginès, Juan Rodés, Alberto Sanchez-Fueyo, Ramon Bataller, Andrés Cárdenas, Vicente Arroyo, Mónica Guevara, Pere Ventura, Gloria Fernández-Esparrach
Publikováno v:
Journal of Hepatology. 34:46-52
Background/Aims : Parameters evaluating renal function and systemic hemodynamics are of prognostic significance in cirrhosis with ascites but are rarely used in the evaluation of survival of these patients. The aim of the current study was to develop
Autor:
Miquel Navasa, JM Salmerón, Andrés Cárdenas, Pere Ginès, Juan Rodés, Vicente Arroyo, Ramon Bataller, Juan Uriz, Antoni Mas, Wladimiro Jiménez, Pau Sort
Publikováno v:
Journal of Hepatology. 33:43-48
Ornipressin, a vasopressin analog with potent splanchnic vasoconstrictor action, has been shown to reverse hepatorenal syndrome. However, its usefulness in clinical practice is limited by frequent ischemic complications. The aim of this study was to